Pharmaceutical Industry in India is very huge in market size. It is worth 14 Billion USD currently and is growing. The pharma sector not only fulfills the domestic needs but also exports medicines abroad. Top Indian pharma companies are lead by Dr Reddy's, Lupin, Cipla, Cadila followed by brands like Sun, Torrent, Aurobindo etc.
Here is a list of Top 10 Pharma Companies in India 2016 on the basis of Revenue, Profit and R&D Expenditure.
Top Pharma Companies in India 2016 are:
1st Dr Reddy's Laboratories
2nd Lupin Pharmaceuticals
3rd Cipla Pharmaceuticals
4th Cadila Pharmaceuticals
5th Aurobindo Pharmaceuticals
6th Torrent Pharmaceuticals
7th Glenmark Pharmaceuticals
8th Sun Pharmaceuticals
9th Divis Laboratories
10th Piramal Enterprises
For More details about parameters and rankings, read on.
10. PIRAMAL ENTERPRISES
Piramal Enterprises which was formerly named as Nicholas Piramal is one of the largest pharma companies in India.
The company was founded in 1988 and has its headquarters in Mumbai in the state of Maharashtra. Ajay Piramal is the current chairman of the company and It is a part of Piramal Group, its healthcare division forms a major part of the group.
Apart from Healthcare, Piramal Group is also operating in areas of retail, glass manufacturing as well as real estate. The Piramal Healthcare operates two divisions which are Pharma and Healthcare solutions. The manufacturing facilities for Healthcare solutions is located in Himanchal Pradesh and Maharashtra while manufacturing facilities for Pharma solutions are located in Tamil Nadu, Andhra Pradesh, UK and Canada. PHL has its presence globally in Asia, North America and Europe.
The Pharmaceutical segment consists of Pharma solutions, OTC, Critical Care, Life sciences and Ophthalmology.
Entire drug cycle which covers all the processes from manufacturing to supplies of API comes under the purview of Pharma solutions.
It’s OTC and Ophthalmology division includes popular products like Equal, Caladryl and Saridon. The compounds are optimized and discovered by life sciences division in the areas of Imaging and Bio-orthopedics.
It is the only company with a complete portfolio of IA (Inhalation Anesthesia) drugs and is the third largest player in global IA market.
In 2015, Piramal expanded its ability to make sterile injectable products by acquiring Coldstream Laboratories. Piramal invested approximately 60 crores to fuel its R&D division and make innovative products.